Oral Oncology
Volume 40, Issue 1 , Pages 43-51 , January 2004

Gefitinib (‘Iressa’, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, up-regulates p27KIP1 and induces G1 arrest in oral squamous cell carcinoma cell lines

Received 24 April 2003 ,Accepted 27 May 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1368-8375(03)00131-3

doi: 10.1016/S1368-8375(03)00131-3

Oral Oncology
Volume 40, Issue 1 , Pages 43-51 , January 2004

Article Tools

* Image Usage & Resolution